University of Padua

Overview

The PhD program in Clinical and Experimental Oncology and Immunology at the University of Padua offers a comprehensive approach to the study of cancer and its treatments. This doctoral training integrates laboratory research with a focus on clinically oriented oncology and immunology, enabling students to acquire essential research skills in tumor biology, molecular pathology, and cancer immunotherapy over a typical duration of 36 months.

What you'll study

Programme Structure: The PhD program combines an individualized research project conducted in collaboration with participating laboratories alongside a series of structured core courses aimed at enhancing scientific, methodological, and communication competencies.

Core courses may include:

• Scientific English
• Biostatistics
• Topics in Oncology and Cancer Virology
• Genetics and Bioinformatic Analyses
• Oncohematology

Research areas include:

• Bioinformatics approaches for tumor studies
• Cyto-histopathology and molecular pathology in oncology
• Tumor immunology and immunotherapy strategies
• Molecular markers linked to therapy response in solid tumors
• Hematological malignancies
• Genetic predisposition to cancer
• Oncogenes and tumor suppressor genes in tumor development
• Locoregional treatment strategies
• Urogenital tract tumors
• Viral oncology

Thesis requirement: Students are expected to complete their doctoral research project and submit a PhD thesis, with detailed requirements outlined in the official program regulations.

Entry requirements

To apply for this program, candidates must possess a second-level university degree (or equivalent) that qualifies them for doctoral studies in Italy. Acceptable qualifications include:

• diploma di laurea (pre-reform regime);
• laurea specialistica/magistrale (post-reform regime);
• Second-level academic qualifications awarded by AFAM institutions (Higher Education in Art and Music).

Specific GRE/GMAT requirements and GPA thresholds are not explicitly stated.

Career prospects

Graduates of the PhD program in Clinical and Experimental Oncology and Immunology will be well-equipped to pursue careers in academia, research institutions, pharmaceutical companies, and healthcare organizations. They will play a vital role in advancing the understanding and treatment of cancer through innovative research and development in the fields of oncology and immunology.